{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:19:46Z","timestamp":1768317586255,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s13365-014-0251-9","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T13:55:43Z","timestamp":1398261343000},"page":"362-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study"],"prefix":"10.1007","volume":"20","author":[{"given":"Alicia","family":"Gonz\u00e1lez-Baeza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Bay\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"P\u00e9rez-Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Est\u00e9banez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose I.","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Monge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Lagarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Arnalich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"251_CR1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789\u20131799","journal-title":"Neurology"},{"key":"251_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/QAD.0b013e3283348944","volume":"24","author":"JR Arribas","year":"2010","unstructured":"Arribas JR, Horban A, Gerstoft J, F\u00e4tkenheuer G, Nelson M, Clumeck N, Pulido F, Hill A, van Delft Y, Stark T, Moecklinghoff C (2010) The MONET trial: darunavir\/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies\/ml. AIDS 24:223\u2013230. doi: 10.1097\/QAD.0b013e3283348944","journal-title":"AIDS"},{"issue":"6","key":"251_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s13365-012-0127-9","volume":"18","author":"T Bunupuradah","year":"2012","unstructured":"Bunupuradah T, Chetchotisakd P, Jirajariyavej S, Valcour V, Bowonwattanuwong C, Munsakul W, Klinbuayaem V, Prasithsirikul W, Sophonphan J, Mahanontharit A, Hirschel B, Bhakeecheep S, Ruxrungtham K, Ananworanich J (2012) Neurocognitive impairment in patients randomized to second-line lopinavir\/ritonavir-based antiretroviral therapy vs. lopinavir\/ritonavir monotherapy. J Neurovirol 18(6):479\u2013487. doi: 10.1007\/s13365-012-0127-9","journal-title":"J Neurovirol"},{"key":"251_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/135965350300800103","volume":"8","author":"L Chang","year":"2003","unstructured":"Chang L, Ernst T, Witt MD, Ames N, Walot I, Jovicich J, DeSilva M, Trivedi N, Speck O, Miller EN (2003) Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antivir Ther 8:17\u201326","journal-title":"Antivir Ther"},{"key":"251_CR5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","volume":"76","author":"N Ciccarelli","year":"2011","unstructured":"Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, Tamburrini E, Cauda R, De Luca A, Silveri MC (2011) Efavirenz associated with neurocognitive impairment in otherwise asymptomatic HIV-infected patients. Neurology 76:1403\u20131409. doi: 10.1212\/WNL.0b013e31821670fb","journal-title":"Neurology"},{"key":"251_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3851\/IMP2560","volume":"18","author":"N Ciccarelli","year":"2013","unstructured":"Ciccarelli N, Fabbiani M, Colafigli M, Trecarichi EM, Silveri MC, Cauda R, Murri R, De Luca A, Di Giambenedetto S (2013) Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia. Antivir Ther 18:153\u2013160. doi: 10.3851\/IMP2560","journal-title":"Antivir Ther"},{"key":"251_CR7","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale, New Jersey","edition":"2"},{"key":"251_CR8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.0b013e31827f0776","volume":"80","author":"NF Crum-Cianflone","year":"2013","unstructured":"Crum-Cianflone NF, Moore DJ, Letendre S, PoehlmanRoediger M, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR (2013) Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology 80:371\u2013379. doi: 10.1212\/WNL.0b013e31827f0776","journal-title":"Neurology"},{"key":"251_CR9","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/archneur.61.11.1699","volume":"61","author":"LAJ Cysique","year":"2004","unstructured":"Cysique LAJ, Maruff P, Brew BJ (2004) Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 61:1699\u20131704","journal-title":"Arch Neurol"},{"key":"251_CR10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/01.wnl.0000210477.63851.d3","volume":"66","author":"LA Cysique","year":"2006","unstructured":"Cysique LA, Maruff P, Brew BJ (2006) Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66:1447\u20131450","journal-title":"Neurology"},{"key":"251_CR11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","volume":"73","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73:342\u2013348. doi: 10.1212\/WNL.0b013e3181ab2b3b","journal-title":"Neurology"},{"issue":"6","key":"251_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1310\/hct1206-333","volume":"12","author":"L Garvey","year":"2011","unstructured":"Garvey L, Surendrakumar V, Winston A (2011) Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV ClinTrialsHIVClin Trials 12(6):333\u2013338. doi: 10.1310\/hct1206-333","journal-title":"HIV ClinTrialsHIVClin Trials"},{"issue":"1","key":"251_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.31887\/DCNS.2012.14.1\/pharvey","volume":"14","author":"PD Harvey","year":"2012","unstructured":"Harvey PD (2012) Clinical applications of neuropsychological assessment. Dialogues Clin Neurosci 14(1):91\u201399","journal-title":"Dialogues Clin Neurosci"},{"key":"251_CR14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087\u20132096. doi: 10.1212\/WNL.0b013e318200d727","journal-title":"Neurology"},{"issue":"1","key":"251_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Igor Grant I, CHARTER Group, HNRC Group (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3\u201316. doi: 10.1007\/s13365-010-0006-1","journal-title":"J Neurovirol"},{"key":"251_CR16","unstructured":"Howell D (2002). Statistical methods for psychology, 5th ed."},{"key":"251_CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1468-1293.2012.01052.x","volume":"14","author":"Y Kahouadji","year":"2013","unstructured":"Kahouadji Y, Dumurgier J, Sellier P, Lapalus P, Delcey V, Bergmann J, Hugon J, Paquet C (2013) Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score. HIV Med 14:311\u2013315","journal-title":"HIV Med"},{"key":"251_CR18","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/QAD.0b013e32833dec20","volume":"24","author":"C Katlama","year":"2010","unstructured":"Katlama C, Valantin MA, Algarte-Genin M, Duvivier C, Lambert-Niclot S, Girard PM, Molina JM, Hoen B, Pakianather S, Peytavin G, Marcelin AG, Flandre P (2010) Efficacy of darunavir\/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. AIDS 24:2365. doi: 10.1097\/QAD.0b013e32833dec20","journal-title":"AIDS"},{"key":"251_CR19","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/jac\/dkr229","volume":"66","author":"I Perez-Valero","year":"2011","unstructured":"Perez-Valero I, Bayon C, Cambron I, Gonz\u00e1lez A, Arribas JR (2011) Protease inhibitor monotherapy and the CNS: peace of mind? J Antimicrob Chemother 66:1954\u20131962. doi: 10.1093\/jac\/dkr229","journal-title":"J Antimicrob Chemother"},{"key":"251_CR20","doi-asserted-by":"crossref","first-page":"e69493","DOI":"10.1371\/journal.pone.0069493","volume":"8","author":"I P\u00e9rez-Valero","year":"2013","unstructured":"P\u00e9rez-Valero I, Gonz\u00e1lez-Baeza A, Est\u00e9banez M, Montes-Ram\u00edrez ML, Bay\u00f3n C, Pulido F, Bernardino JI, Zamora FX, Monge S, Gaya F, Lagarde M, Rubio R, Hernando A, Arnalich F, Arribas JR (2013) Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy. PLoS One 8:e69493. doi: 10.1371\/journal.pone.0069493","journal-title":"PLoS One"},{"key":"251_CR21","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e3282f4243b","volume":"22","author":"F Pulido","year":"2008","unstructured":"Pulido F, Arribas JR, Delgado R, Cabrero E, Gonz\u00e1lez-Garc\u00eda J, P\u00e9rez-Elias MJ, Arranz A, Portilla J, Pasquau J, Iribarren JA, Rubio R, Norton M (2008) Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. AIDS 22:F1\u2013F9","journal-title":"AIDS"},{"key":"251_CR22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.57.3.542","volume":"57","author":"N Sacktor","year":"2001","unstructured":"Sacktor N, Tarwater PM, Skolasky RL, McArthur JC, Selnes OA, Becker J, Cohen B, Miller EN (2001) CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology 57:542\u2013544","journal-title":"Neurology"},{"key":"251_CR23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1212\/01.WNL.0000076477.71313.6E","volume":"61","author":"N Sacktor","year":"2003","unstructured":"Sacktor N, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Visscher B, Miller EN (2003) Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology 61:567\u2013569","journal-title":"Neurology"},{"key":"251_CR24","doi-asserted-by":"crossref","first-page":"e70201","DOI":"10.1371\/journal.pone.0070201","volume":"8","author":"JR Santos","year":"2013","unstructured":"Santos JR, Mu\u00f1oz-Moreno JA, Molt\u00f3 J, Prats A, Curran A, Domingo P, Llibre JM, McClernon DR, Bravo I, Canet J, Watson V, Back D, Clotet B (2013) Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir\/ritonavir: an exploratory study. PLoS One 8:e70201","journal-title":"PLoS One"},{"issue":"11","key":"251_CR25","first-page":"4","volume":"14","author":"LJ Seidman","year":"1998","unstructured":"Seidman LJ (1998) Neuropsychological testing. Harv Ment Health Lett 14(11):4\u20136","journal-title":"Harv Ment Health Lett"},{"key":"251_CR26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","volume":"24","author":"S Simioni","year":"2010","unstructured":"Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24:1243\u20131250","journal-title":"AIDS"},{"key":"251_CR27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","volume":"25","author":"M Smurzynski","year":"2011","unstructured":"Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R (2011) Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS 25:357\u2013365. doi: 10.1097\/QAD.0b013e32834171f8","journal-title":"AIDS"},{"key":"251_CR28","first-page":"387","volume":"308","author":"MA Thompson","year":"2012","unstructured":"Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, G\u00fcnthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA (2012) Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 308:387\u2013402. doi: 10.1001\/jama.2012.7961","journal-title":"JAMA"},{"issue":"1","key":"251_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QAI.0b013e3181af83d6","volume":"52","author":"V Tozzi","year":"2009","unstructured":"Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A (2009) Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr 52(1):56\u201363","journal-title":"J Acquir Immune Defic Syndr"},{"key":"251_CR30","doi-asserted-by":"crossref","first-page":"e61949","DOI":"10.1371\/journal.pone.0061949","volume":"8","author":"A Winston","year":"2013","unstructured":"Winston A, Arenas-Pinto A, St\u00f6hr W, Fisher M, Orkin CM, Aderogba K et al (2013) Neurocognitive function in HIV infected patients on antiretroviral therapy. PLoS ONE 8:e61949. doi: 10.1371\/journal.pone.0061949","journal-title":"PLoS ONE"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-014-0251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-014-0251-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-014-0251-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T10:19:02Z","timestamp":1689157142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-014-0251-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1007\/s13365-014-0251-9","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}